These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35265619)

  • 1. Embryonic Hypotaurine Levels Contribute to Strain-Dependent Susceptibility in Mouse Models of Valproate-Induced Neural Tube Defects.
    Steele JW; Lin YL; Chen N; Wlodarczyk BJ; Chen Q; Attarwala N; Venkatesalu M; Cabrera RM; Gross SS; Finnell RH
    Front Cell Dev Biol; 2022; 10():832492. PubMed ID: 35265619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolite profiling of whole murine embryos reveals metabolic perturbations associated with maternal valproate-induced neural tube closure defects.
    Akimova D; Wlodarczyk BJ; Lin Y; Ross ME; Finnell RH; Chen Q; Gross SS
    Birth Defects Res; 2017 Jan; 109(2):106-119. PubMed ID: 27860192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos.
    Padmanabhan R; Shafiullah M; Benedict S; Nagelkerke N
    Eur J Nutr; 2006 Sep; 45(6):311-9. PubMed ID: 16699836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation.
    Padmanabhan R; Shafiullah MM
    Congenit Anom (Kyoto); 2003 Mar; 43(1):29-40. PubMed ID: 12692401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
    Dawson JE; Raymond AM; Winn LM
    Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratogenicity of valproate conjugates with anticonvulsant activity in mice.
    Spiegelstein O; Chatterjie N; Alexander G; Finnell RH
    Epilepsy Res; 2003 Dec; 57(2-3):145-52. PubMed ID: 15013055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NRF2 activation inhibits valproic acid-induced neural tube defects in mice.
    Piorczynski TB; Lapehn S; Ringer KP; Allen SA; Johnson GA; Call K; Lucas SM; Harris C; Hansen JM
    Neurotoxicol Teratol; 2022; 89():107039. PubMed ID: 34737154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.
    Nau H; Hauck RS; Ehlers K
    Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione.
    Hishida R; Nau H
    Teratog Carcinog Mutagen; 1998; 18(2):49-61. PubMed ID: 9704382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects.
    Tung EW; Winn LM
    Mol Pharmacol; 2011 Dec; 80(6):979-87. PubMed ID: 21868484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
    Massa V; Wlodarczyk B; Giavini E; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Shared Pathogenic Mechanism for Valproic Acid and
    Takla TN; Luo J; Sudyk R; Huang J; Walker JC; Vora NL; Sexton JZ; Parent JM; Tidball AM
    Cells; 2023 Jun; 12(13):. PubMed ID: 37443734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
    Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M
    Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Environment Interactions in the Etiology of Neural Tube Defects.
    Finnell RH; Caiaffa CD; Kim SE; Lei Y; Steele J; Cao X; Tukeman G; Lin YL; Cabrera RM; Wlodarczyk BJ
    Front Genet; 2021; 12():659612. PubMed ID: 34040637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice.
    Spiegelstein O; Merriweather MY; Wicker NJ; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):974-8. PubMed ID: 14745917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestational exposure to valproic acid upregulates total Stat3 protein expression while downregulating phosphorylated Stat3 in CD-1 mouse embryos with neural tube defects.
    Shafique S; Winn LM
    Birth Defects Res; 2020 Apr; 112(7):555-568. PubMed ID: 32134217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribonucleotide reductase subunit R1: a gene conferring sensitivity to valproic acid-induced neural tube defects in mice.
    Craig JC; Bennett GD; Miranda RC; Mackler SA; Finnell RH
    Teratology; 2000 Apr; 61(4):305-13. PubMed ID: 10716750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative genomics reveals pathogenic mediator of valproate-induced neurodevelopmental disability.
    Feleke R; Jazayeri D; Abouzeid M; Powell KL; Srivastava PK; O'Brien TJ; Jones NC; Johnson MR
    Brain; 2022 Nov; 145(11):3832-3842. PubMed ID: 36071595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid-induced alterations in growth and neurotrophic factor gene expression in murine embryos [corrected].
    Bennett GD; Wlodarczyk B; Calvin JA; Craig JC; Finnell RH
    Reprod Toxicol; 2000; 14(1):1-11. PubMed ID: 10689198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.